Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Socinski

Showing results (1-10 of 279) with videos related to

Pageof 28
Sort By:
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Highlights in NSCLC from the American Society of Clinical Oncology Meeting, June 3-7, 2011, Chicago, Illinois, USAMark A Socinski
Clinical Advances in Hematology & Oncology : H&O|October 18, 2017
How I treat stage IV non-small cell lung cancer in the absence of any actionable oncogenic driverMark A Socinski
Respiratory Care Clinics of North America|August 13, 2003
The role of chemotherapy in the treatment of unresectable stage III and IV nonsmall cell lung cancerMark A Socinski
Seminars in Oncology|April 9, 2005
Pemetrexed (Alimta) in small cell lung cancerMark A Socinski
Seminars in Oncology|October 20, 2015
Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-IntroductionMark A Socinski
Clinical Lung Cancer|November 24, 2004
Adjuvant therapy of resected non-small-cell lung cancerMark A Socinski
Cancer Treatment Reviews|June 7, 2011
Multitargeted receptor tyrosine kinase inhibition: an antiangiogenic strategy in non-small cell lung cancerMark A Socinski
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
The current status and evolving role of sunitinib in non-small cell lung cancerMark A Socinski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Antibodies to the epidermal growth factor receptor in non small cell lung cancer: current status of matuzumab and panitumumabMark A Socinski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Cytotoxic chemotherapy in advanced non-small cell lung cancer: a review of standard treatment paradigmsMark A Socinski
Pageof 28

Showing results (1-10 of 279) with videos related to

Sort By:
Pageof 28
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Highlights in NSCLC from the American Society of Clinical Oncology Meeting, June 3-7, 2011, Chicago, Illinois, USAMark A Socinski
Clinical Advances in Hematology & Oncology : H&O|October 18, 2017
How I treat stage IV non-small cell lung cancer in the absence of any actionable oncogenic driverMark A Socinski
Respiratory Care Clinics of North America|August 13, 2003
The role of chemotherapy in the treatment of unresectable stage III and IV nonsmall cell lung cancerMark A Socinski
Seminars in Oncology|April 9, 2005
Pemetrexed (Alimta) in small cell lung cancerMark A Socinski
Seminars in Oncology|October 20, 2015
Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-IntroductionMark A Socinski
Clinical Lung Cancer|November 24, 2004
Adjuvant therapy of resected non-small-cell lung cancerMark A Socinski
Cancer Treatment Reviews|June 7, 2011
Multitargeted receptor tyrosine kinase inhibition: an antiangiogenic strategy in non-small cell lung cancerMark A Socinski
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
The current status and evolving role of sunitinib in non-small cell lung cancerMark A Socinski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Antibodies to the epidermal growth factor receptor in non small cell lung cancer: current status of matuzumab and panitumumabMark A Socinski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Cytotoxic chemotherapy in advanced non-small cell lung cancer: a review of standard treatment paradigmsMark A Socinski
Pageof 28